Study reveals some of the fundamental biology of p97 protein in neurodegenerative disease

The p97 protein is one of your body's best garbage disposers. It floats around in your cells looking for signals that a protein is past its shelf life and needs to be trashed. Mutations in this protein have been linked to neurodegenerative diseases, such as ALS and dementia, but p97's relationship to these disorders is still being explored. A study by researchers at Tufts University School of Medicine, published February 6 in Nature Communications, reveals some of the fundamental biology of p97, highlighting its role in ensuring our cellular organelles are in constant sync with one another.

p97 works with numerous binding partners called co-factors, which help target p97 to proteins that need to be eliminated. The research team found that p97, in coordination with one of its co-factors UBXD8, help regulate the kinds of proteins present where a cell's mitochondria (which produces energy for the cell) and endoplasmic reticulum (a network of membranes inside the cell that traffic proteins to different cellular destinations) connect. These contacts, which allow the organelles to provide status updates or transfer cargo, are very sensitive to disturbances. When the p97-UBXD8 complex is absent, specific molecules accumulate on the endoplasmic reticulum membranes causing them to stick to the mitochondria.

However, what was surprising about their findings is that the molecules that collected at these contacts relayed information which caused the membranes to become more rigid. In fact, they found that if they could change the relative rigidity of the membranes at contacts, they could modulate how the contacts formed and dissipated.

We're always thinking about neurogenerative diseases caused by p97 mutation in terms of a protein not getting disposed and therefore accumulating and aggregating until it becomes a problem. But this study suggests that p97 mutation can also lead to miscommunication between organelles. It's important for organelles to make these minute-to-minute decisions, and so we're really interested in trying to see how this communication goes awry in disease."

Malavika Raman, senior author, assistant professor, department of developmental, molecular and chemical biology, School of Medicine, Tufts University

To test whether what they were observing in lab dishes happens in animals, the research team used mouse models of p97 mutants that cause neurodegeneration. Their experiments confirmed that the proteins they found to be changing at organelle contacts were also altered in the brains of these mice, negatively impacting the interplay between the organelles.

"This is exciting because we have always thought about p97 mutations as a protein quality control defect, but now it appears that lipid metabolism may also be a significant contributor," says first author Rakesh Ganji, a postdoctoral scholar in the Raman Lab. "Disruption of contacts and inherent lipid synthesis is emerging as a hallmark in a variety of human disorders such as neurodegeneration."

The research team is next exploring what happens when human neurons have p97 mutations, and if there's anything that can be done to help these neurons survive when organelle communication and protein disposal breaks down.

Research reported in this article was supported by the National Institutes of Health's National Institute of General Medical Services under award number R01GM127557, National Institute of Allergy and Infectious Diseases under award number R01AI162671, and the National Institute on Aging under award numbers T32AG058503 and R01AG031867, the University of Arizona Health Sciences and BIO5 Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.

Journal reference:

Ganji, R., et al. (2023) The p97-UBXD8 complex regulates ER-Mitochondria contact sites by altering membrane lipid saturation and composition. Nature Communications.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Precision-guided treatment boosts outcomes in children with high-risk cancers